NCT05018793View on ClinicalTrials.gov

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Spinal Cord Injuries
Interventions
BIOLOGICAL

autologous adipose derived mesenchymal stem cells

cultured autologous adult adipose derived mesenchymal stem cells

BIOLOGICAL

AlloRx

Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal injection for

Trial Locations (2)

16675

RECRUITING

Athens Beverly Hills Medical Group, Glyfada

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER